Case Report
Volume 9 Issue 5 - 2022
Nonspecific Aortoarteritis, Case Presentation and Literature Review
Sayfutdinov Rafik Galimzyanovich1*, Gabitov SZ1, Mtusheva EI1 and Khadeeva VZ2
1Department of Hospital and Polyclinic Therapy of KSMA - Branch Campus of the FSBEI FPE RMACPE MOH Russia, Russia
2City Clinical Hospital № 12, Kazan, Russia
*Corresponding Author: Sayfutdinov Rafik Galimzyanovich, Doctor of Medical Sciences, Head of the Department of Hospital and Polyclinic Therapy KSMA - Branch Campus of the FSBEI FPE RMACPE MOH Russia, Kazan, Russia.
Received: February 01, 2022; Published: April 29, 2022




Abstract

We present a case of delayed diagnosed aortoarteritis who respond dramatically to immunosuppressive therapy stressing the needs of early diagnosis of such cases.

Keywords: A Nonspecific Aortoarteritis; Takayasu’s Disease

References

  1. Pokrovsky AV., et al. “Clinical guidelines Aortoarteritis nonspecific in adults". M., (2016): 23.
  2. Smitienko IO. “Clinical variants of organ lesions, assessment of the activity and prognosis of Takayasu's arteritis”. Author's abstract ... cand. honey. sciences (2010): 22.
  3. Arend WP., et al. “The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis”. Arthritis and Rheumatology 8 (1990): 1129-1134.
  4. Batu ED., et al. “Tocilizumab treatment in childhood Takayasu arteritis: case series of four patients and systematic review of the literature”. Seminars in Arthritis and Rheumatism 4 (2017): 529-535.
  5. Bravo Manche-o B., et al. “Successful tocilizumab treatment in a child with refractory Takayasu arteritis”. Pediatrics 6 (2012): e1720-e1724.
  6. Dai D., et al. “The efficacy of mycophenolate mofetil in treating Takayasu arteritis: a systematic review and meta-analysis”. Rheumatology International 7 (2017): 1083-1088.
  7. Eleftheriou D., et al. “Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom”. Arthritis Research and Therapy 1 (2015): 36.
  8. Goel R., et al. “Rapid control of disease activity by Tocilizumab in 10 difficult to treat' cases of Takayasu arteritis”. International Journal of Rheumatic Diseases 6 (2013): 754-761.
  9. Goel R., et al. “Childhood-onset Takayasu arteritis-experience from a tertiary care center in South India”. Journal of Rheumatology 6 (2014): 1183-1189.
  10. Hoffman GS and Ahmed AE. “Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS)”. International Journal of Cardiology 1 (1998): S191-S194.
  11. Ishihara T., et al. “Sensitive assessment of activity of Takayasu's arteritis by pentraxin3, a new biomarker”. Journal of the American College of Cardiology 16 (2011): 1712-1713.
  12. Ishikawa K. “Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy”. Journal of the American College of Cardiology 4 (1988): 964-972.
  13. Katsicas MM., et al. “Arteritis de Takayasu en pediatría”. Archivos Argentinos de Pediatria 3 (2012): 251-255.
  14. Kerr GS., et al. “Takayasu arteritis”. Annals of Internal Medicine 11 (1994): 919-929.
  15. Kothari S. “Takayasu's arteritis in children-a review”. Images in Paediatric Cardiology 3 (2001): 4-23.
  16. Liang P and Hoffman GS. “Advances in the medical and surgical treatment of Takayasu arteritis”. Current Opinion in Rheumatology 1 (2005): 16-24.
  17. Maeda H., et al. “Carotid lesions detected by B-mode ultrasonography in Takayasu's arteritis: “macaroni sign” as an indicator of the disease”. Ultrasound in Medicine and Biology 7 (1991): 695-701.
  18. Nakaoka Y., et al. “Tocilizumab for the treatment of patients with refractory takayasu arteritis”. International Heart Journal 6 (2013): 405-411.
  19. Mason JC. “Takayasu arteritis-advances in diagnosis and management”. Nature Reviews Rheumatology 7 (2010): 406-415.
  20. Mathew AJ., et al. “Childhood-onset Takayasu arteritis: an update”. International Journal of Rheumatic Diseases 2 (2016): 116-126.
  21. McCulloch M., et al. “Angiographic features of 26 children with Takayasu's arteritis”. Pediatric Radiology 4 (2003): 230-235.
  22. Nishimoto N., et al. “Successful treatment of a patient with Takayasu's arteritis using a humanized anti-interleukin 6 receptor antibody”. Arthritis and Rheumatology 4 (2008): 1197-1200.
  23. Morales E., et al. “Takayasu's arteritis in children”. Journal of Rheumatology 7 (1991): 1081-1084.
  24. Mukhtyar C., et al. “EULAR recommendations for the management of large vessel vasculitis”. Annals of the Rheumatic Diseases 3 (2009): 318-323.
  25. Pan L., et al. “Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu's arteritis: a case-control study”. BMJ Open4 (2017): e014451.
  26. Reinhold-Keller E., et al. “Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register”. Arthritis and Rheumatology 1 (2005): 93-99.
  27. Sadurska E., et al. “Takayasu arteritis as a cause of arterial hypertension. Case report and literature review”. European Journal of Pediatrics 5 (2012): 863-869.
  28. Salvarani C., et al. “Tocilizumab: a novel therapy for patients with large-vessel vasculitis”. Rheumatology1 (2012): 151-156.
  29. Salvarani C., et al. “Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis”. Clinical and Experimental Rheumatology 6 (2003): S23-S28.
  30. Schmidt W. “Role of ultrasound in the understanding and management of vasculitis”. Therapeutic Advances in Musculoskeletal Disease 2 (2014): 39-47.
  31. Szugye HS., et al. “Takayasu Arteritis in the pediatric population: a contemporary United States-based single center cohort”. Pediatric Rheumatology Online Journal 12 (2014): 21.
  32. Tombetti E., et al. “Treatment of refractory takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center”. Journal of Rheumatology12 (2013): 2047-2051.
  33. Unizony S., et al. “Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatic”. Arthritis Care and Research 11 (2012): 1720-1729.
  34. Watanabe Y., et al. “Current clinical features of new patients with Takayasu arteritis observed from Cross-Country Research in Japan”. Circulation 18 (2015): 1701-1709.
  35. Yamada I., et al. “Takayasu arteritis: evaluating with MR imaging”. Radiology1 (1993): 89-94.
  36. Zhou J., et al. “The efficacy of tocilizumab for the treatment of Chinese Takayasu's arteritis”. Clinical and Experimental Rheumatology 103 (2017): 171-175.
Citation: Sayfutdinov Rafik Galimzyanovich., et al. “Nonspecific Aortoarteritis, Case Presentation and Literature Review”. EC Gastroenterology and Digestive System 9.5 (2022): 68-74.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


July Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the July issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before July 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.